Latest Breaking News On - Doug drysdale - Page 4 : comparemela.com

Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program

- Newly issued patents include protection for injectable formulations and synthesis methods for the preparation of dimethyltryptamine and deuterated DMT - - Patent protection further strengthens.

United statesUnited kingdomDoug drysdaleExchange commissionHealth canadaJapan patent officeJapan patent jp officeDrug administrationCybin incJapan patentGeneralized anxiety disorderChief executive officer

Cybin Inc (CYBN) Granted Two Additional Patents in Japan in Support of DMT Program

Cybin Inc (CYBN) Granted Two Additional Patents in Japan in Support of DMT Program
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDoug drysdaleDrug administrationCybin incJapan patent jp officeJapan patent officeJapan patentGeneralized anxiety disorderChief executive officer

InvestorNewsBreaks – Cybin Inc (NYSE American: CYBN) (NEO: CYBN) Secures Two New JP Patents, Further Broadening IP Portfolio in Key Markets

InvestorNewsBreaks – Cybin Inc (NYSE American: CYBN) (NEO: CYBN) Secures Two New JP Patents, Further Broadening IP Portfolio in Key Markets
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesDoug drysdaleLos angelesJapan patent officeJapan patent jp officeCybin incJapan patentDynamic brand portfolio

FN MEDIA GROUP LLC: How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition

FN MEDIA GROUP LLC: How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomNew jerseyUnited statesStefan klotterRob barrowSsris snrisBeckley psytechRaj mehraAzapirone buspironeDoug drysdaleExchange commissionLife sciencesCybin incHackensack meridian healthSecurities exchangeFn media group

Cybin Announces FDA Clearance to Initiate a Phase 2a Study of CYB004 in Generalized Anxiety Disorder

- Recently announced positive Phase 1 topline safety, pharmacokinetic and pharmacodynamic data show that intravenous CYB004 demonstrated robust and rapid-onset psychedelic effects at lower doses.

United statesUnited kingdomDoug drysdalePsychiatric sciencesHealth canadaDrug administrationExchange commissionCybin incGeneralized anxiety disorderChief executive officerGlobal burdenDisease study